hospira™ ceftriaxone sodium powder for injection
pfizer new zealand limited - ceftriaxone sodium 2.39 g equivalent to ceftriaxone 2 g - powder for injection - 2 g - active: ceftriaxone sodium 2.39 g equivalent to ceftriaxone 2 g - ceftriaxone sodium is indicated for the treatment of lower respiratory tract infections when caused by susceptible aerobic organisms
penicillin g sodium injection
sandoz new zealand limited - benzylpenicillin sodium 600mg equivalent to benzylpenicillin 1,000,000 iu (sterile) - powder for injection - 1e+006 iu - active: benzylpenicillin sodium 600mg equivalent to benzylpenicillin 1,000,000 iu (sterile)
chloramphenicol 1% eye ointment
martindale pharmaceuticals ltd - chloramphenicol - eye ointment - 10mg/1gram
cefotaxime injection cefotaxime 2g (as sodium) powder for injection vial
lupin australia pty limited - cefotaxime sodium, quantity: 2097 mg (equivalent: cefotaxime, qty 2000 mg) - injection, powder for - excipient ingredients: - cefotaxime injection is indicated for the treatment of the following types of infection when caused by susceptible micro-organisms. infections of the respiratory tract (upper and lower). infections of the urinary tract. septicaemia - concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. intra-abdominal infection. gonorrhoea (including gonorrhoea caused by beta-lactamase producing strains of n. gonorrhoeae.) ear, nose and throat (ent) infections. skin and skin structure infections. bone and joint infections. meningitis - cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or penicillin g) for initial therapy in children, (excluding neonates), pending the availability of culture and sensitivity results. in adults the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by gram-negative enteric bacilli. cefotaxime injection may be used for the prevention of post-operative infection in obstetric surgery, vaginal and abdominal hysterectomy and biliary surgery. in serious cases, cefotaxime injection may be used, if considered appropriate, before the results of sensitivity tests become available. the emergence of resistance to cefotaxime may complicate treatment.
cefotaxime injection cefotaxime 1g (as sodium) powder for injection vial
lupin australia pty limited - cefotaxime sodium, quantity: 1048 mg (equivalent: cefotaxime, qty 1000 mg) - injection, powder for - excipient ingredients: - cefotaxime injection is indicated for the treatment of the following types of infection when caused by susceptible micro-organisms. infections of the respiratory tract (upper and lower). infections of the urinary tract. septicaemia - concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. intra-abdominal infection. gonorrhoea (including gonorrhoea caused by beta-lactamase producing strains of n. gonorrhoeae.) ear, nose and throat (ent) infections. skin and skin structure infections. bone and joint infections. meningitis - cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or penicillin g) for initial therapy in children, (excluding neonates), pending the availability of culture and sensitivity results. in adults the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by gram-negative enteric bacilli. cefotaxime injection may be used for the prevention of post-operative infection in obstetric surgery, vaginal and abdominal hysterectomy and biliary surgery. in serious cases, cefotaxime injection may be used, if considered appropriate, before the results of sensitivity tests become available. the emergence of resistance to cefotaxime may complicate treatment.
cefotaxime hexal cefotaxime 500mg (as sodium) powder for injection vial
lupin australia pty limited - cefotaxime sodium, quantity: 524 mg (equivalent: cefotaxime, qty 500 mg) - injection, powder for - excipient ingredients: - cefotaxime hexal injection is indicated for the treatment of the following types of infection when caused by susceptible micro-organisms. infections of the respiratory tract (upper and lower). infections of the urinary tract. septicaemia - concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. intra-abdominal infection. gonorrhoea (including gonorrhoea caused by beta-lactamase producing strains of n. gonorrhoeae.) ear, nose and throat (ent) infections. skin and skin structure infections. bone and joint infections. meningitis - cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or penicillin g) for initial therapy in children, (excluding neonates), pending the availability of culture and sensitivity results. in adults the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by gram-negative enteric bacilli. cefotaxime hexal injection may be used for the prevention of post-operative infection in obstetric surgery, vaginal and abdominal hysterectomy and biliary surgery. in serious cases, cefotaxime hexal injection may be used, if considered appropriate, before the results of sensitivity tests become available. the emergence of resistance to cefotaxime may complicate treatment.
cefotaxime sodium for injection 500mg powder for solution for injection or infusion
villerton invest s.a. rue edward steichen 14, 2540, luxembourg - cefotaxime sodium - powder for solution for injection/infusion - cefotaxime sodium 500/2.2 mci/ml - antibacterials for systemic use
chloromycetin 1g lyophilized powder for injection im/iv
pfizer inc - chloramphenicol sodium succinate - lyophilized powder for injection im/iv - 1g
chloramphenicol 0.5% eye drops
a a h pharmaceuticals ltd - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
the boots company plc - chloramphenicol - eye drops - 5mg/1ml